Abstract
References
Mutch WJ, Dingwall-Fordyce I, Downie AW, et al. Parkinson 's disease in a Scottish City. Br Med J (Clin Res Ed) 1986;292:534-536. Available from: https://doi.org/10.1136/bmj.292.6519.534
Ward CD, Duvoison RC, Ince SE, et al. Parkinson 's disease in 65 pairs of twins and in a set of quadruplets. Neurology 1983;33:815-824. Available from: https://doi.org/10.1212/wnl.33.7.815
Koller W, Vetere-Overfield B, Gray C, et al. Environmental risk factors in Parkinson's disease. Neurology. 1990;40(8):1218-21
Barbeau A, Roy M, Cloutier T, et al. Environmental and genetic factors in the etiology of Parkinson 's disease. Advances in Neurology 1987;45:299-306
Langston JW, MPTP. The promise of a new neurotoxin. In: Marsden CD, Fahn, eds. Movement disorders 2. Butterworths: London; 1987;73-90
Brown RG, Marsden CD. How common is dementia in Parkinson 's disease? Lancet. 1984;2(8414):1262-5. Available from: https://doi.org/10.1016/s0140-6736(84)92807-1
Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med. 1989;321(20):1364-71. Available from: https://doi.org/10.1056/NEJM198911163212004